Area of research
Pharmacology · Molecular Biology
Research interest
Research focused on Apoptosis and Isoliquiritigenin, with related work in MAPK/ERK pathway, Protein kinase B, Hepatocellular carcinoma. Notable publications include 'Mechanisms underlying isoliquiritigenin‐induced apoptosis and cell cycle arrest via ROS‐mediated MAPK/STAT3/NF‐κB pathways in human hepatocellular carcinoma cells', 'Liquiritin inhibits proliferation and induces apoptosis in HepG2 hepatocellular carcinoma cells via the ROS-mediated MAPK/AKT/NF-κB signaling pathway', and 'Deep learning assists detection of esophageal cancer and precursor lesions in a prospective, randomized controlled study'.
Deep learning assists detection of esophageal cancer and precursor lesions in a prospective, randomized controlled study
Liquiritin inhibits proliferation and induces apoptosis in HepG2 hepatocellular carcinoma cells via the ROS-mediated MAPK/AKT/NF-κB signaling pathway
Mechanisms underlying isoliquiritigenin‐induced apoptosis and cell cycle arrest via ROS‐mediated MAPK/STAT3/NF‐κB pathways in human hepatocellular carcinoma cells